These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24585878)

  • 1. Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10.
    MacDonald KP; Le Texier L; Zhang P; Morris H; Kuns RD; Lineburg KE; Leveque L; Don AL; Markey KA; Vuckovic S; Bagger FO; Boyle GM; Blazar BR; Hill GR
    J Immunol; 2014 Apr; 192(7):3180-9. PubMed ID: 24585878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant mobilization of both conventional and regulatory T cells with AMD3100.
    Kean LS; Sen S; Onabajo O; Singh K; Robertson J; Stempora L; Bonifacino AC; Metzger ME; Promislow DE; Mattapallil JJ; Donahue RE
    Blood; 2011 Dec; 118(25):6580-90. PubMed ID: 21989987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.
    Lundqvist A; Smith AL; Takahashi Y; Wong S; Bahceci E; Cook L; Ramos C; Tawab A; McCoy JP; Read EJ; Khuu HM; Bolan CD; Joo J; Geller N; Leitman SF; Calandra G; Dunbar C; Kurlander R; Childs RW
    J Immunol; 2013 Dec; 191(12):6241-9. PubMed ID: 24244025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of donor hematopoietic cells mobilized with G-CSF and plerixafor on murine acute graft-versus-host-disease.
    Arbez J; Saas P; Lamarthée B; Malard F; Couturier M; Mohty M; Gaugler B
    Cytotherapy; 2015 Jul; 17(7):948-55. PubMed ID: 25813681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
    Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
    Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory γδ T cells induced by G-CSF participate in acute graft-versus-host disease regulation in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation.
    Xuan L; Wu X; Qiu D; Gao L; Liu H; Fan Z; Huang F; Jin Z; Sun J; Li Y; Liu Q
    J Transl Med; 2018 May; 16(1):144. PubMed ID: 29801459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
    MacDonald KP; Rowe V; Filippich C; Thomas R; Clouston AD; Welply JK; Hart DN; Ferrara JL; Hill GR
    Blood; 2003 Mar; 101(5):2033-42. PubMed ID: 12393418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.
    Xuan L; Wu X; Zhang Y; Fan Z; Ling Y; Huang F; Zhang F; Zhai X; Liu Q
    J Transl Med; 2011 Dec; 9():215. PubMed ID: 22171570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of the mobilization with AMD3100, granulocyte-colony-stimulating factor (G-CSF) alone and in combination on the immunological function of the lymphocytes in mice].
    Kong Y; Feng R; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):358-61. PubMed ID: 22781791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?
    Morris ES; MacDonald KP; Hill GR
    Blood; 2006 May; 107(9):3430-5. PubMed ID: 16380448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF-treated donor CD4+ T cells attenuate acute GVHD through a reduction in Th17 cell differentiation.
    Joo YD; Lee WS; Won HJ; Lee SM; Kim HR; Park JK; Park SG; Choi IW; Choi I; Seo SK
    Cytokine; 2012 Oct; 60(1):277-83. PubMed ID: 22819244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of granulocyte colony-stimulating factor mobilization on the expression patterns, clonality and signal transduction of TRAV and TRBV repertoire.
    Xuan L; Wu X; Wu M; Zhang Y; Liu H; Fan Z; Sun J; Liu Q
    Immunobiology; 2012 Aug; 217(8):816-22. PubMed ID: 22658922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.
    Larochelle A; Krouse A; Metzger M; Orlic D; Donahue RE; Fricker S; Bridger G; Dunbar CE; Hematti P
    Blood; 2006 May; 107(9):3772-8. PubMed ID: 16439684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
    Nademanee AP; DiPersio JF; Maziarz RT; Stadtmauer EA; Micallef IN; Stiff PJ; Hsu FJ; Bridger G; Bolwell BJ
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1564-72. PubMed ID: 22683613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.
    Morris ES; MacDonald KP; Rowe V; Banovic T; Kuns RD; Don AL; Bofinger HM; Burman AC; Olver SD; Kienzle N; Porcelli SA; Pellicci DG; Godfrey DI; Smyth MJ; Hill GR
    J Clin Invest; 2005 Nov; 115(11):3093-103. PubMed ID: 16224535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?
    Cashen AF; Lazarus HM; Devine SM
    Bone Marrow Transplant; 2007 May; 39(10):577-88. PubMed ID: 17369869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.
    Vendramin A; Gimondi S; Bermema A; Longoni P; Rizzitano S; Corradini P; Carniti C
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2049-55. PubMed ID: 25246295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In and out of the niche: perspectives in mobilization of hematopoietic stem cells.
    Mohty M; Ho AD
    Exp Hematol; 2011 Jul; 39(7):723-9. PubMed ID: 21624427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor.
    Teipel R; Oelschlägel U; Wetzko K; Schmiedgen M; Kramer M; Rücker-Braun E; Hölig K; von Bonin M; Heidrich K; Fuchs A; Ordemann R; Kroschinsky F; Bornhäuser M; Hütter G; Schmidt H; Ehninger G; Schetelig J; Heidenreich F
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2171-2177. PubMed ID: 29935214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.